KIEV, March 4 – Companies that are members of the of Indian Pharmaceutical Manufacturers' Association in Ukraine (IPMA) have presented the conditions of production of medicines at their plants in India to Ukrainian MPs – representatives of the Ukraine-India parliamentary committees for healthcare, preventing and combating corruption and the budget committee.

During the visit the Ukrainian parliamentary delegation visited in Gurgaon one of the research and development centers of Sun Pharmaceutical Industries Ltd., production facilities of Dr.Reddy's, Optimus Generics Ltd., which is part of Organosyn Lifesciences Pvt. Ltd. and produces officinal medicines for Organosyn Ltd. that operates in Ukraine, the production facilities of Aurobindom one of the largest companies that have a full pharmaceutical production cycle from active pharmaceutical ingredients to officinal medicines, and a plant of Lupin pharmaceutical company located in Goa, one of 15 plants of the corporation.